Cwc Advisors, Llc. Tg Therapeutics, Inc. Transaction History
Cwc Advisors, Llc.
- $101 Billion
- Q3 2024
A detailed history of Cwc Advisors, Llc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Cwc Advisors, Llc. holds 16,150 shares of TGTX stock, worth $375,810. This represents 0.37% of its overall portfolio holdings.
Number of Shares
16,150Holding current value
$375,810% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
295Shares Held
91.6MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$319 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$265 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$156 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$84.8 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$75.5 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.38B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...